![Andrew Saich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Saich
Keine laufenden Positionen mehr
Profil
Andrew Saich is the founder of Avata Biosciences, founded in 2024, holding the title of Chief Medical Officer.
Dr. Saich is also the founder of Diligence, Inc...
Dr. Saich currently works at Return Health, Inc. as Chief Medical Officer.
Former positions include Medical Director at Encysive Pharmaceuticals, Inc., Seqirus Vaccines Ltd., Shield Holdings AG; Medical Director-European Region at Intercept Pharmaceuticals, Inc.; Medical Director-United Kingdom Region at ALTANA Pharma US, Inc.; Non-Executive Director at Nexalis Therapeutics Ltd. from 2021 to 2024; General Manager at Kudu Medical Ltd.; and Chief Medical Officer at Senzer Ltd. Education includes undergraduate studies at the University of London and both undergraduate and doctorate degrees from the University of Westminster.
Aktive Positionen von Andrew Saich
| Unternehmen | Position | Beginn |
|---|---|---|
Return Health, Inc.
 Return Health, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures transformative psychedelic medicines for dementia | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Andrew Saich
| Unternehmen | Position | Ende |
|---|---|---|
| NEXALIS THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 28.11.2024 |
Diligence, Inc.
 Diligence, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business intelligence and analysis services | Gründer | - |
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Senzer Ltd.
 Senzer Ltd. Medical SpecialtiesHealth Technology Manufactures respiratory devices | Technik-/Wissenschafts-/F&E-Leiter | - |
Kudu Medical Ltd. | Corporate Officer/Principal | - |
Ausbildung von Andrew Saich
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
18
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Seqirus Vaccines Ltd.
 Seqirus Vaccines Ltd. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Diligence, Inc.
Diligence, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business intelligence and analysis services | Commercial Services |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Westminster
 University of Westminster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ALTANA Pharma US, Inc.
 ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets respiratory and gastrointestinal products | Health Technology |
Shield Holdings AG
 Shield Holdings AG Pharmaceuticals: MajorHealth Technology Develops and commercializes late stage pharma products | Health Technology |
Kudu Medical Ltd. | |
InhaleRx Ltd.
 InhaleRx Ltd. Medical DistributorsDistribution Services Develops and sells thermometers | Distribution Services |
Senzer Ltd.
Senzer Ltd. Medical SpecialtiesHealth Technology Manufactures respiratory devices | Health Technology |
Return Health, Inc.
Return Health, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures transformative psychedelic medicines for dementia | Health Technology |
